Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: lined (742)

Report of Voting_UHS

Description: Report of Voting UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST ELECTION TO THE COUNCIL OF GOVERNORS CLOSE OF VOTING: 5PM ON 25
Url: /Media/UHS-website-2019/Docs/Council-of-Governors/Report-of-Voting-UHS.pdf

Cisplatin-Lomustine-Vincristine (Packer LCV3)

Description: Chemotherapy Protocol Central Nervous System CISPLATIN-LOMUSTINE-VINCRISTINE (Packer LCV3) Regimen • CNS – Cisplatin-Lomustine-Vincristine (Packer LCV3) Indication • Adjuvant treatment for
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CNS/Cisplatin-Lomustine-Vincristine-Packer-LCV3.pdf

Report of voting - UHS - 2022

Description: Report of Voting UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST ELECTION TO THE COUNCIL OF GOVERNORS CLOSE OF VOTING: 5PM ON 26
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Governors/Report-of-voting-UHS-2022.pdf

Vinorelbine (oral day 1, 8 and 15)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Oral) (Day 1, 8, 15) This protocol may require funding Regimen NSCLC
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineoralday18and15ver11.pdf

Vinorelbine (oral day 1 and 8)

Description: Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) VINORELBINE (Oral) (Day 1 and 8) This protocol may require funding Regimen NSCLC
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Vinorelbineoralday1and8ver11.pdf

Dabrafenib Trametinib Ver1

Description: Chemotherapy Protocol SKIN CANCER DABRAFENIB-TRAMETINIB Regimen  Skin – Dabrafenib-Trametinib Indication  The combination of dabrafenib and trametinib is recommended as an
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibTrametinibVer1.pdf

Health and safety policy

Description: Health and Safety Policy Date Issued: 21/11/18 Review Date: 21/11/21 Document Type: Policy Version: 10.0 Contents
Url: /Media/UHS-website-2019/Docs/Policies/Health-and-safety-policy.pdf

VAC31518COV2001_UK_Parent and Guardian ICF_V2.0_15Feb2021_Clean Localised (1)

Description: Southampton NIHR Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level West Wing, Mailpoint 2
Url: /Media/Southampton-Clinical-Research/Downloads/VAC31518COV2001-UK-Parent-and-Guardian-ICF-V2.0-15Feb2021-Clean-Localised-1.pdf

VAC31518COV2001_UK_Young Person_ Patient Information Sheet ICF_V2.0_15Feb2021_Clean Localised (3)

Description: Southampton NIHR Clinical Research Facility University Hospital Southampton NHS Foundation Trust C Level West Wing, Mailpoint 2
Url: /Media/Southampton-Clinical-Research/Downloads/VAC31518COV2001-UK-Young-Person-Patient-Information-Sheet-ICF-V2.0-15Feb2021-Clean-Localised-3.pdf

Press release: Leading doctor warns use of blood test to diagnose heart attacks is 'flawed'

Description: A leading cardiac specialist has said some patients who suffer suspected heart attacks could be receiving inappropriate investigations and unnecessary treatment
Url: /AboutTheTrust/Newsandpublications/Latestnews/2019/March/Press-release-Leading-doctor-warns-use-of-blood-test-to-diagnose-heart-attacks-is-flawed.aspx

71 to 80 of 587

Previous … 6 7 8 9 10 … Next